Pembroke Pines, FLNCT07541287Now EnrollingIRB Ready

IgA Nephropathy Clinical Trial in Pembroke Pines, FL

Access cutting-edge iga nephropathy treatment through this clinical trial at a research site in Pembroke Pines. Study-provided care at no cost to qualified participants.

Sponsored by Jade Biosciences, Inc.

Quick Self-Assessment

See if you qualify for this Pembroke Pines location

Preparing your pre-screening questions…

Expert Care in Pembroke Pines

Access iga nephropathy specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related iga nephropathy treatment provided free

Apply for This Pembroke Pines Location

Check if you qualify for this iga nephropathy clinical trial in Pembroke Pines, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Pembroke Pines

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Pembroke Pines site if eligible
  4. 4Begin participation

About This IgA Nephropathy Study in Pembroke Pines

This open-label Phase 2 study will characterize the safety and efficacy of JADE101 in participants with IgA nephropathy, and the results will contribute to the overall clinical characterization of JADE101 in this patient population.

Sponsor: Jade Biosciences, Inc.

Who Can Participate

Inclusion Criteria

Male or female participants 18-60 years of age, inclusive, and of local legal consenting age at the time of signing the informed consent
eGFR ≥ 30 mL/min/1.73 m2
Biopsy-confirmed primary IgAN
Receiving stable and maximally tolerated doses of either ACEi or ARB as per standard of care (SoC) and applicable guidelines for at least 12 weeks prior to the initial screening visit, with no intention to alter the dose or discontinue treatment, unless medically necessary
UPCR ≥ 0.75 g/g
Willing to provide written informed consent
Willing and able to comply with scheduled study visits, treatment plans, laboratory tests, and other study procedures
Willing and able to comply with contraceptive and lifestyle requirements

Exclusion Criteria

Secondary forms of IgAN
Known or suspected coexisting Chronic Kidney Disease (CKD) other than IgAN
Known or suspected rapidly progressive glomerulonephritis (RPGN)
Evidence of pathological findings in the kidney biopsy in addition to IgAN (eg, minimal change disease, diabetic kidney disease, membranous nephropathy, focal segmental glomerulosclerosis, or lupus nephritis); hypertensive vascular changes are acceptable
Known or suspected primary or secondary immunodeficiency disorder
Evidence of tuberculosis infection at screening
Any chronic infectious disease
Any acute infectious disease at time of screening
Received bone marrow, hematologic stem cell transplantation, or a solid organ transplant, including kidney
Known or suspected alcohol or drug abuse
Any clinically significant and/or unstable or uncontrolled medical condition as assessed by the investigator
Malignancy within the past 5 years; nonmelanoma skin cancer and curatively treated cervical carcinoma in situ are allowed Other protocol-defined inclusion/exclusion criteria may apply

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Pembroke Pines?

Yes, this clinical trial (NCT07541287) has an active research site in Pembroke Pines, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

IgA Nephropathy Treatment Options in Pembroke Pines, FL

If you're searching for iga nephropathy treatment options in Pembroke Pines, FL, this clinical trial (NCT07541287) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Pembroke Pines research site is actively enrolling participants for this clinical trial. You'll receive care from experienced iga nephropathy specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all iga nephropathy clinical trials near you to find additional studies recruiting in your area.

More IgA Nephropathy Trials in Pembroke Pines, FL

See all iga nephropathy clinical trials recruiting in Pembroke Pines — not just this study.

Browse IgA Nephropathy Trials in Pembroke Pines →

Browse More Trials by Condition

IgA Nephropathy TrialsPulmonary Hypertension TrialsGeographic Atrophy TrialsAll Conditions →

Ready to Join in Pembroke Pines?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Pembroke Pines, FL